drugset / Trial / NCT05594316

New Treatment of Alopecia Areata

NCT05594316

Completed 40 enrolled Al-Azhar University
NaSingle-groupOpen-labelTreatment

Summary

Abstract: Alopecia areata is believed to be an autoimmune disease resulting from a breach in the immune privilege of the hair follicles causing non scarring hair loss. Methods: our study included 40 patients from may 2019 to july 2022 diagnosed clinically, dermatoscopically and pathologically as alopecia areata Data were enrolled from department of dermatology and venereology, Al-Hussein hospital.

Timeline

Start
2019-05-01
Primary completion
2022-08-01
Completion
2022-10-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Trichloroacetic acid Small molecule 35 %

Indications